S&P 500   4,582.04 (+0.72%)
DOW   36,080.15 (+0.07%)
QQQ   390.13 (+1.32%)
AAPL   194.77 (+1.27%)
MSFT   369.62 (+0.22%)
META   326.72 (+2.92%)
GOOGL   136.79 (+5.21%)
AMZN   147.11 (+1.79%)
TSLA   243.12 (+1.57%)
NVDA   462.75 (+1.70%)
NIO   7.51 (-3.10%)
BABA   72.13 (+0.90%)
AMD   125.26 (+7.22%)
T   17.01 (+0.41%)
F   10.82 (+1.22%)
MU   73.64 (+0.70%)
CGC   0.71 (+1.79%)
GE   118.73 (-0.90%)
DIS   92.89 (+1.52%)
AMC   6.83 (+0.59%)
PFE   28.84 (+0.17%)
PYPL   58.50 (-1.73%)
XOM   99.23 (+0.12%)
S&P 500   4,582.04 (+0.72%)
DOW   36,080.15 (+0.07%)
QQQ   390.13 (+1.32%)
AAPL   194.77 (+1.27%)
MSFT   369.62 (+0.22%)
META   326.72 (+2.92%)
GOOGL   136.79 (+5.21%)
AMZN   147.11 (+1.79%)
TSLA   243.12 (+1.57%)
NVDA   462.75 (+1.70%)
NIO   7.51 (-3.10%)
BABA   72.13 (+0.90%)
AMD   125.26 (+7.22%)
T   17.01 (+0.41%)
F   10.82 (+1.22%)
MU   73.64 (+0.70%)
CGC   0.71 (+1.79%)
GE   118.73 (-0.90%)
DIS   92.89 (+1.52%)
AMC   6.83 (+0.59%)
PFE   28.84 (+0.17%)
PYPL   58.50 (-1.73%)
XOM   99.23 (+0.12%)
S&P 500   4,582.04 (+0.72%)
DOW   36,080.15 (+0.07%)
QQQ   390.13 (+1.32%)
AAPL   194.77 (+1.27%)
MSFT   369.62 (+0.22%)
META   326.72 (+2.92%)
GOOGL   136.79 (+5.21%)
AMZN   147.11 (+1.79%)
TSLA   243.12 (+1.57%)
NVDA   462.75 (+1.70%)
NIO   7.51 (-3.10%)
BABA   72.13 (+0.90%)
AMD   125.26 (+7.22%)
T   17.01 (+0.41%)
F   10.82 (+1.22%)
MU   73.64 (+0.70%)
CGC   0.71 (+1.79%)
GE   118.73 (-0.90%)
DIS   92.89 (+1.52%)
AMC   6.83 (+0.59%)
PFE   28.84 (+0.17%)
PYPL   58.50 (-1.73%)
XOM   99.23 (+0.12%)
S&P 500   4,582.04 (+0.72%)
DOW   36,080.15 (+0.07%)
QQQ   390.13 (+1.32%)
AAPL   194.77 (+1.27%)
MSFT   369.62 (+0.22%)
META   326.72 (+2.92%)
GOOGL   136.79 (+5.21%)
AMZN   147.11 (+1.79%)
TSLA   243.12 (+1.57%)
NVDA   462.75 (+1.70%)
NIO   7.51 (-3.10%)
BABA   72.13 (+0.90%)
AMD   125.26 (+7.22%)
T   17.01 (+0.41%)
F   10.82 (+1.22%)
MU   73.64 (+0.70%)
CGC   0.71 (+1.79%)
GE   118.73 (-0.90%)
DIS   92.89 (+1.52%)
AMC   6.83 (+0.59%)
PFE   28.84 (+0.17%)
PYPL   58.50 (-1.73%)
XOM   99.23 (+0.12%)

Zura Bio Stock Price, News & Analysis (NASDAQ:ZURA)

$3.99
-0.03 (-0.75%)
(As of 11:37 AM ET)
Compare
Today's Range
$3.92
$4.07
50-Day Range
$4.00
$7.00
52-Week Range
$3.91
$37.55
Volume
46,423 shs
Average Volume
315,813 shs
Market Capitalization
$171.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.60

Zura Bio MarketRank™ Stock Analysis

Analyst Rating
Buy
3.20 Rating Score
Upside/​Downside
316.0% Upside
$16.60 Price Target
Short Interest
Healthy
0.83% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.74) to ($0.98) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

298th out of 958 stocks

Biological Products, Except Diagnostic Industry

44th out of 146 stocks


ZURA stock logo

About Zura Bio Stock (NASDAQ:ZURA)

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.

ZURA Stock Price History

ZURA Stock News Headlines

Short Interest in Zura Bio Limited (NASDAQ:ZURA) Decreases By 62.9%
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Zura Bio GAAP EPS of -$0.18
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Zura Bio Ltd. Wt
Where Zura Bio Stands With Analysts
ZURAW Zura Bio Limited WT EXP 032028
Zura Bio Ltd (94E)
Zura Bio (NASDAQ: ZURA)
What's Going On With Zura Bio Stock Today
Why Shares of Zura Bio Climbed Tuesday
Why Is Zura Bio (ZURA) Stock Up 9% Today?
See More Headlines
Receive ZURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zura Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
12/07/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/26/2024

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZURA
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.60
High Stock Price Target
$22.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+312.9%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Net Income
$3.55 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.86 per share
Book Value
($2.21) per share

Miscellaneous

Free Float
36,285,000
Market Cap
$173.22 million
Optionable
Not Optionable
Beta
0.54
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. David Brady
    Head of Business Development
  • Dr. Someit Sidhu M.D. (Age 34)
    CEO & Director
  • Mr. Verender S. Badial (Age 51)
    Chief Financial Officer
  • Dr. Gary Whale (Age 49)
    Chief Technology Officer
  • Dr. Michael D. Howell Ph.D. (Age 46)
    Chief Scientific Officer & Head of Translational Science
  • Ms. Kimberly Ann Davis (Age 55)
    Chief Legal Officer & Secretary
  • Ms. Theresa Lowry (Age 49)
    Chief Human Resources Officer
  • Dr. Christopher H. Cabell FACC (Age 54)
    M.D., MHS, Chief Medical Officer, Executive VP and Head of R&D














ZURA Stock Analysis - Frequently Asked Questions

Should I buy or sell Zura Bio stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zura Bio in the last year. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ZURA shares.
View ZURA analyst ratings
or view top-rated stocks.

What is Zura Bio's stock price target for 2024?

5 analysts have issued 12-month price objectives for Zura Bio's shares. Their ZURA share price targets range from $10.00 to $22.00. On average, they anticipate the company's share price to reach $16.60 in the next year. This suggests a possible upside of 316.0% from the stock's current price.
View analysts price targets for ZURA
or view top-rated stocks among Wall Street analysts.

How have ZURA shares performed in 2023?

Zura Bio's stock was trading at $29.42 at the start of the year. Since then, ZURA stock has decreased by 86.4% and is now trading at $3.99.
View the best growth stocks for 2023 here
.

Are investors shorting Zura Bio?

Zura Bio saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 171,200 shares, a decrease of 62.9% from the October 31st total of 461,900 shares. Based on an average trading volume of 129,700 shares, the short-interest ratio is presently 1.3 days. Currently, 0.8% of the company's stock are short sold.
View Zura Bio's Short Interest
.

When is Zura Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 26th 2024.
View our ZURA earnings forecast
.

How were Zura Bio's earnings last quarter?

Zura Bio Limited (NASDAQ:ZURA) announced its quarterly earnings data on Monday, November, 13th. The company reported ($0.18) EPS for the quarter, beating analysts' consensus estimates of ($0.25) by $0.07.

Who are Zura Bio's major shareholders?

Zura Bio's stock is owned by a variety of retail and institutional investors. Top institutional investors include Armistice Capital LLC (3.67%), Silverarc Capital Management LLC (0.94%), Invesco Ltd. (0.27%), Eisler Capital US LLC (0.23%), Northern Trust Corp (0.22%) and Charles Schwab Investment Management Inc. (0.22%).
View institutional ownership trends
.

How do I buy shares of Zura Bio?

Shares of ZURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ZURA) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -